BCAX

Bicara Therapeutics Inc.

Contracts

Total Value

Stock Metrics

26.2%

Short % Float

20.4d to cover · High squeeze

1.1%

Inst % Float

10 holders · 2026-06-30

RA Capital Managem

Top Holder

11.0% of float

36.6M sh

Public Float

33/100

Dilution Score

Medium

72 mo

Cash Runway

Verified regulatory filings & proprietary analysis.

Dilution Risk

33/100

MEDIUM

Inst: 1.11% · Top: RA Capital Management, L.P.

Biotech Analytics

Biotech / Pharma

36.47

Squeeze risk: HIGHBiotech Grade: D

Insider Buying0

Publications100

Dilution Risk33

Clinical Trials54

Short Interest70